Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCM Jindan Withdrawal Pellet for Lymphatic Leakage After Pelvic Lymphadenectomy
ChiCTR2400081955Phase 2Recruiting
- Sponsor
- The Second Hospital of Tianjin Medical University
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Jindan Fuyan Granule in bladder cancer and lymphatic fistula (2 arms), sponsored by The Second Hospital of Tianjin Medical University. Primary endpoint: volume of drainage. Started Mar 2024; status: recruiting.
02
Drugs
Jindan Fuyan Granule
03
Conditions
bladder cancerlymphatic fistula
Beyond the preview
Go deeper on ChiCTR2400081955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081955.